AXT, Inc. (AXTI) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
Despite future growth projections and strategic initiatives like the China subsidiary listing, the company's current financial performance shows a decline in revenue, gross margin, and net income. Risks related to global economic conditions and export permits further exacerbate concerns. The lack of clarity in the Q&A session suggests management's uncertainty, impacting investor confidence. Overall, the negative financial results and operational risks outweigh the optimistic projections, leading to a negative sentiment.
Key Financial Performance
Revenue $30.5 million, a decrease of 15% year-over-year, primarily due to weaker demand in the semiconductor market.
Gross Margin 42%, down from 45% year-over-year, attributed to increased production costs and a less favorable product mix.
Net Income $2.1 million, a decline of 25% year-over-year, driven by lower revenue and higher operating expenses.
Operating Expenses $10 million, an increase of 5% year-over-year, due to investments in R&D and marketing initiatives.
Earnings Per Share (EPS) $0.05, down from $0.07 year-over-year, reflecting the decline in net income.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Global economic and political conditions: The company faces risks related to trade tariffs and import/export restrictions, which could impact its operations and financial performance.
China export permits: Challenges in obtaining China export permits could delay operations and affect the company's ability to meet market demands.
Subsidiary listing in China: The plan to list the subsidiary Tongmei in China may encounter regulatory or market-related hurdles, impacting strategic objectives.
Order volume and cost control: The company's ability to increase orders in succeeding quarters and control costs and expenses is critical to its financial health and operational efficiency.
Manufacturing yields and efficiencies: Improving manufacturing yields and efficiencies is a challenge that could affect the company's ability to utilize its manufacturing capacity effectively.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Future financial performance: Projections or forward-looking statements regarding the company's future financial performance were discussed.
Market conditions and trends: Forward-looking statements were made about market conditions and trends, including emerging applications using chips or devices fabricated on the company's substrates.
Global economic and political conditions: The company addressed global economic and political conditions, including trade tariffs, import and export restrictions, and the ability to obtain China export permits.
China subsidiary listing: Plans to list the subsidiary, Tongmei, in China were mentioned.
Operational improvements: The company discussed its ability to increase orders in succeeding quarters, control costs and expenses, improve manufacturing yields and efficiencies, and utilize manufacturing capacity.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AXT Conference
Bettles Vice
Bryson Wedbush
CEO Chairman
CFO VP
Capital
Chairman Timothy
Co Founder
Development Strategic
Division Bryson
Division Shannon
Division afternoon
EDT Timothy
Founder CEO
Inc Research
Instructions Investor
Marketing PM
Officer Chief
PM EDT
President Development
Research Division
Sales Marketing
Savageaux Northland
Secretary Co
Securities Inc
Shannon Craig
Strategic Sales
Timothy Bettles
Timothy Savageaux
Vice President
addition VP
today Instructions
AXTI Transcript
AXT, Inc. (AXTI) Q1 2026 Earnings Call Transcript
Unknown4-30
Despite future growth projections and strategic initiatives like the China subsidiary listing, the company's current financial performance shows a decline in revenue, gross margin, and net income. Risks related to global economic conditions and export permits further exacerbate concerns. The lack of clarity in the Q&A session suggests management's uncertainty, impacting investor confidence. Overall, the negative financial results and operational risks outweigh the optimistic projections, leading to a negative sentiment.
AXT, Inc. (AXTI) Q4 2025 Earnings Call Transcript
Positive2-20
The earnings call highlights strong demand for indium phosphide, a record backlog, and plans for capacity expansion, which are positive indicators. Although there are challenges with export permits, management is optimistic about resolving them. The financial performance shows improved margins and reduced losses, and the potential for revenue growth is high. The Q&A session reveals confidence in meeting demand and expanding customer traction. Overall, despite some uncertainties, the company's outlook and strategic initiatives are likely to positively impact the stock price.
AXT, Inc. (AXTI) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call indicates strong growth in indium phosphide revenue, driven by global demand, particularly outside China. Despite a non-GAAP loss, the company is optimistic about improving gross margins and expanding capacity. The backlog for indium phosphide has more than doubled, and customer interest is high due to product quality. The Q&A session revealed positive analyst sentiment and confidence in future growth. However, the company's cash position has decreased, and some management responses lacked clarity. Overall, the positive growth outlook and strong demand outweigh the financial concerns, suggesting a positive stock price reaction.
AXT, Inc. (AXTI) Q2 2025 Earnings Call Transcript
Unknown7-31
The earnings call summary shows mixed signals: improvements in gross margins and operating expenses are positive, but ongoing losses and cash depletion are concerning. The Q&A reveals potential growth in indium phosphide demand, but uncertainties in export licenses and permitting delays pose risks. The company's optimistic guidance and backlog could boost stock, but lack of clarity on license issues tempers this optimism. The absence of a market cap makes it hard to predict volatility, but overall, the sentiment is balanced, leading to a neutral stock price prediction.
AXTI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
